Taub Rebecca — SEC Form 4 filings
SEC reporting owner CIK 1423898. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-01-18 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 91 legs across 13 filings — 196,141 shares, $68,172,992 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 18,917 shares @ $245.34 ($4,641,014) in MADRIGAL PHARMACEUTICALS, INC., filed 2024-04-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 17 | — | 91 legs · 196,141 sh · $68,172,992 | 33 |
Form 4 filings — Taub Rebecca
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 454 @ $0 · Grant/award (A): 766 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 491 @ $431.94 | EDGAR |
| 2026-01-26 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 647 @ $492.42 | EDGAR |
| 2026-01-20 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 2,238 @ $490.77 | EDGAR |
| 2026-01-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 18,410 @ $15.80 · Sale (S): 960 @ $512.02 · Sale (S): 960 @ $513.12 · Sale (S): 937 @ $514.63 · Sale (S): 1,578 @ $515.82 · Sale (S): 521 @ $516.81 · +24 more | EDGAR |
| 2026-01-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 240 @ $15.80 · Sale (S): 40 @ $545.79 · Sale (S): 200 @ $551.24 · Option exercise (M): 240 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 18,650 @ $15.80 · Sale (S): 491 @ $547.76 · Sale (S): 369 @ $548.56 · Sale (S): 486 @ $550.07 · Sale (S): 4,723 @ $550.99 · Sale (S): 4,410 @ $551.85 · +6 more | EDGAR |
| 2025-08-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 3,200 @ $9.45 · Sale (S): 2,980 @ $350.18 · Sale (S): 220 @ $351.02 · Option exercise (M): 43,263 @ $9.45 · Sale (S): 3,580 @ $350.87 · Sale (S): 2,870 @ $351.60 · +10 more | EDGAR |
| 2025-07-22 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 1,000 @ $9.45 · Sale (S): 1,000 @ $350.00 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 26,444 @ $9.45 · Sale (S): 6,000 @ $350.19 · Sale (S): 1,897 @ $351.37 · Sale (S): 2,357 @ $352.64 · Sale (S): 2,569 @ $353.82 · Sale (S): 5,800 @ $354.61 · +7 more | EDGAR |
| 2025-03-07 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 4,382 @ $0 · Grant/award (A): 7,381 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 648 @ $335.24 | EDGAR |
| 2025-01-17 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 1,689 @ $273.41 | EDGAR |
| 2024-04-10 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 2,676 @ $9.45 · Sale (S): 224 @ $243.25 · Sale (S): 945 @ $244.79 · Sale (S): 300 @ $245.69 · Sale (S): 600 @ $246.98 · Sale (S): 407 @ $247.76 · +2 more | EDGAR |
| 2024-04-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 27,845 @ $9.45 · Sale (S): 135 @ $242 · Sale (S): 2,634 @ $243.68 · Sale (S): 4,070 @ $244.68 · Sale (S): 18,917 @ $245.34 · Sale (S): 2,089 @ $246.32 · +19 more | EDGAR |
| 2024-01-25 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 5,786 @ $0 · Grant/award (A): 8,718 (derivative) @ $0 · Grant/award (A): 5,786 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Tax withholding (F): 1,546 @ $243.92 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1423898 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →